Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000232220 | SCV000288114 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000563852 | SCV000664505 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001719715 | SCV000714403 | likely benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22972948, 26642834, 23174333, 28724664, 29778030) |
Mendelics | RCV000032785 | SCV001136799 | likely benign | Mitochondrial complex II deficiency, nuclear type 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818204 | SCV002069750 | uncertain significance | not specified | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000563852 | SCV002527718 | benign | Hereditary cancer-predisposing syndrome | 2021-01-12 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001818204 | SCV002773969 | benign | not specified | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001719715 | SCV002821281 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | SDHA: PP3, BS1 |
Mayo Clinic Laboratories, |
RCV001719715 | SCV004227052 | uncertain significance | not provided | 2023-03-23 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000032785 | SCV000056549 | pathogenic | Mitochondrial complex II deficiency, nuclear type 1 | 2012-09-01 | no assertion criteria provided | literature only |